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Abstract
Background: Existing animal models provide only indirect information about the pathogenesis of
infections caused by indigenous gastrointestinal microflora and the kinetics of bacterial
translocation. The aim of this study was to develop a novel animal model to assess bacterial
translocation and intestinal barrier function in vivo.
Methods: In anaesthetized male Wistar rats, 0.5 ml of a suspension of green fluorescent protein-
transfected E. coli was administered by intraluminal injection in a model of small bowel obstruction.
Animals were randomly subjected to non-ischemic or ischemic bowel obstruction. Ischemia was
induced by selective clamping of the terminal mesenteric vessels feeding the obstructed bowel loop.
Time intervals necessary for translocation of E. coli into the submucosal stroma and the muscularis
propria was assessed using intravital microscopy.
Results: Bacterial translocation into the submucosa and muscularis propria took a mean of 36 ± 8
min and 80 ± 10 min, respectively, in small bowel obstruction. Intestinal ischemia significantly
accelerated bacterial translocation into the submucosa (11 ± 5 min, p < 0.0001) and muscularis (66
± 7 min; p = 0.004). Green fluorescent protein-transfected E. coli were visible in frozen sections of
small bowel, mesentery, liver and spleen taken two hours after E. coli administration.
Conclusions: Intravital microscopy of fluorescent bacteria is a novel approach to study bacterial
translocation in vivo. We have applied this technique to define minimal bacterial transit time as a
functional parameter of intestinal barrier function.
Background
Bacterial translocation has been defined as the passage of
viable bacteria from the gut lumen to extraintestinal or-
gans [1]. Major conditions contributing to bacterial trans-
location are a breakdown of the intestinal barrier, an
impairment of host immune defense and a loss of the col-
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onization resistance [2,3] with bacterial overgrowth in the
intestinal tract [4]. Gut bacteria may penetrate the mucosa
– that consists of a tight lining of enterocytes covering the
villi and M-cells in the depth of the crypts [5] – by differ-
ent mechanisms specific to each species [6]. However,
when the mucosa is injured and the intestinal barrier is
compromised [7] an unspecific and unlimited transloca-
tion of intestinal micro-organisms can occur [8]. Intesti-
nal barrier disorders have been studied in a modified
Ussing chamber in vitro [9]. Markers, such as inulin-fluo-
rescein [10] or polyethylene-glycol 4000 [11], fluorescent
microspheres [12] or plasmid-labelled bacteria [13] are
used to study mucosal permeability in vivo. Gut obstruc-
tion and ischemia are severe and often fatal conditions in
patients that can result in sepsis and multiple organ fail-
ure [14,15]. Obstruction [16,17] and ischemia [18,19]
cause mucosal injury with a subsequent increase of mu-
cosal permeability and thus bacterial translocation.
We describe a novel animal model to study bacterial trans-
location under conditions of intestinal obstruction and
ischemia in vivo. Translocation of Escherichia coli (E. coli)
transfected with green fluorescent protein (GFP) can be
observed using intravital microscopy.
Methods
Animals and experimental design
Translocation of GFP-transfected E. coli from an obstruct-
ed segment of terminal ileum across the gut wall and into
distant organs was investigated by intravital microscopy.
Male Wistar rats (200 – 250 g body weight, 12–14 weeks
old) were used for the experiments that were performed in
accordance with German legislation on protection of ani-
mals and the NIH recommendations for the use of labo-
ratory animals [20]. The animals had free access to water
and standard pellet food prior to surgery, so that the integ-
rity of the small bowel mucosa was maintained. Animals
were randomly placed in groups that were either subjected
to non-ischemic or ischemic bowel obstruction. Bowel
obstruction was induced by intestinal ligation. Ischemia
was induced by additional clamping of the mesenteric
blood supply feeding the obstructed segment of ileum.
Sham operated animals without obstruction served as
controls for bacteriological and histopathological exami-
nations. Each group consisted of eight animals.
Transfection and cultivation of E. coli
DH 5a-E-coli were heat-shock transfected with the com-
mercial GFP-uv vector (BD Biosciences Clontech Inc.,
Palo Alto, USA) to produce a stable green fluorescence. E.
coli were incubated with 250 ng DNA, stirred on ice and
heat shocked at 42°C for 60 sec before SOC-transfection
medium was added. The suspension was placed onto
plates covered with Luria-Bertani Medium (LB-medium;
Quiagen, Hilden, Germany). To obtain the necessary bac-
terial concentration before use in the experiments, we in-
cubated E. coli in 100 ml LB-medium over night. Bacterial
concentration (optical density at 600 nm) was checked
and aliquots for the experiments were taken at an optic
density of 1 (8 ×  108 E. Coli/ml).
Surgery
Animals were anaesthetized by i.m. administration of xy-
lazine hydrochloride 100 mg/kg (Rompun, Bayer AB,
Leverkusen, Germany) and ketamine 2.5–5 mg/kg (Hos-
taket, Parke-Davis, Freiburg, Germany). A silicone-cathe-
ter (27 G) was placed into the carotid artery to measure
arterial blood pressure and monitoring blood gases. A sec-
ond catheter was inserted into the contralateral jugular
vein for continuous infusion of saline during experi-
ments. An abdominal cavity chamber was implanted via
an abdominal midline incision as previously described
[21]. In this closed abdominal observation chamber tem-
perature and humidity of the abdominal cavity and the ex-
posed small bowel loop remain constant. Small bowel
obstruction was simulated by proximal and distal ligature
of a segment of terminal ileum two cm in length and two
cm proximal to the cecum, thus forming a reservoir to
hold the bacterial suspension. Perfusion of the obstructed
segment of bowel was maintained through the feeding
mesenteric vessels in one group [22]. In the other group
ischemia was induced by selective clamping of the me-
senteric vessels (Figure 1). The obstructed loop of termi-
nal ileum was externalized onto a horizontal bar inside
the working cylinder of the abdominal cavity chamber,
thereby avoiding any tension on the mesentery. GFP-uv E.
coli (4 ×  108 suspended in 0.5 ml LB-medium) were inject-
ed into the obstructed bowel lumen using a 27G needle.
Injection caused a moderate distension of the obstructed
loop. We carefully avoided any contamination of the ab-
domen. In sham operated animals 0.5 ml of saline were
injected into the terminal ileum. The abdominal cavity
chamber was closed with an optical window leaving the
serosal surface of the bowel exposed underneath. For in-
travital microscopy rats were placed on a heated operating
table (K. Effenberger, Med. Tech. Gerätebau, Pfaffing, Ger-
many) in supine position. Systemic arterial blood pres-
sure and heart rate were monitored continuously (Sirecust
404, Siemens, Erlangen, Germany).
Intravital microscopy
GFP-uv E. coli emit green light (peak at 509 nm, shoulder
at 540 nm) when excited with blue light (at 395 nm max-
imum) [23]. This fluorescence at 540 nm was used to
identify and monitor GFP-uv E. coli translocation through
the gut wall by means of intravital microscopy using a
modified Zeiss microscope (Axiotech, Carl Zeiss, Germa-
ny). Microscopy was performed in 5 minute-intervals to
detect fluorescent bacteria. 10 high power fields (HPF) of
tissue were observed for 10 to 15 sec each in two levels ofBMC Surgery 2002, 2 http://www.biomedcentral.com/1471-2482/2/6
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focus (submucosa and muscularis propria) resulting in a
total observation time of 200–300 sec per observation in-
terval. This 5-minute interval provided a continuous mi-
croscopic observation of the chosen HPFs in both focus
levels. The submucosa is characterized by the submucosal
postcapillary venules, and the muscularis propria is char-
acterized by its typical network of circular and longitudi-
nal muscle capillaries. A 100 W mercury lamp was used
for epiillumination (Carl Zeiss, Germany). A filter (Carl
Zeiss, Germany) protected the tissue against UV illumina-
tion. GFP-uv E. coli were detected by their green fluores-
cence using a 200-fold magnification, and were identified
by their typical shape using a 400-fold magnification. Mi-
croscopic images were recorded with a digital charge-cou-
pled device video camera (KAPPA opto-electronics
GmbH, Gleichen, Germany) and a video cassette recorder
(AG 7350, Panasonic, USA) for off-line evaluation.
Video analysis
Minimal transit time was quantified on-line. Measure-
ments were confirmed off-line by frame to frame compu-
ter-assisted image analysis (Capimage, Zeintl, Heidelberg,
Germany). Minimal transit time was defined as the time
period between GFP-uv E. coli administration into the ob-
structed small bowel segment and the detection of five or
more fluorescent bacterial rods per HPF in ten HPFs.
Bacteriological examination
Samples of mesenteric lymph nodes and stool from the
non-obstructed and the obstructed terminal ileum were
homogenized in sterile isotonic saline using Tenbroeck
tissue grinders (Wheaton, Millville, USA). Each sample
was plated quantitatively on MacConkey and Columbia
blood agar plates (Oxoid, Wesel, Germany) according to
standard methods for culture of aerobic and microaer-
ophilic bacteria. Smears of the abdominal cavity were cul-
tured in the same manner. Anaerobic bacteria were not
assessed. After 48 hours of incubation at 37°C, the colony-
forming units (CFU) per gram of stool were determined.
Bacterial species were identified by gram staining, by their
characteristic biochemical pattern in a commercial system
for biochemical identification of bacteria (API32E, bi-
oMerieux, Nürtingen, Germany) and their characteristic
susceptibility to antibiotics.
Histopathology
Specimens of the obstructed small bowel segment, mesen-
tery, liver and spleen were taken two hours after GFP-uv E.
coli administration for frozen sectioning and paraffin his-
tology. Tissue samples were collected in tissue glue (Tissue
Tek, Sakura, Torrance, USA) which was fixed in ice-cold
isopentane (3-Methyl-1-Butan). Blocks were kept at -80°C
until frozen sections of tissue samples were prepared in 10
µm slices on a Leica Cryostat (Leica, Wetzlar, Germany).
Frozen sections were fixed in mounting medium and ex-
amined for translocation of GFP-uv E. coli using 400-fold
and 630-fold magnification (Leica, Wetzlar, Germany).
GFP-uv fluorescence allowed identification and a topo-
graphical localization of the E. coli within the examined
tissues. Patterns of angioarchitecture were used as land-
marks to correlate cryosections with corresponding hema-
toxylin-eosine (HE) crossections.
For HE histology 10 µm slices were deparaffinized with
ethanol (99%, 96%, 80%), stained for 10 min with hema-
toxylin, washed and counterstained with 0.1% eosin be-
fore being fixed in ethanol. Slides were embedded with
glycerol. Specimens of the obstructed small bowel were
examined for ischemic injury after HE staining, as suggest-
ed by Meddah and co-workers [19]. Lesions were scored
on a scale of 0–3: no or minimal lesions (grade 0), loss of
epithelial cells from the villi (grade 1), sporadic necrosis
of villi (grade 2), and complete mucosal necrosis (grade
3).
Statistical analysis
Minimal transit times of GFP-uv E. coli-translocation into
the submucosal stroma and into the muscularis propria
are expressed as means ± s.d. The significance of differenc-
Figure 1
Small bowel obstruction is simulated by proximal and distal
ligation of the gut lumen two cm in length and two cm proxi-
mal to the ileocecal junction. Ischemia of the small bowel res-
ervoir can be induced by selective clamping of the terminal
mesenteric vessels ( ). !BMC Surgery 2002, 2 http://www.biomedcentral.com/1471-2482/2/6
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es was evaluated using Student's t-test. Differences were
considered significant, if the p-value was <0.05. SAS 8.0®
software (SAS, Cary, NC) was employed for statistical
analysis.
Results
All animals survived the experimental period of two
hours. Mean arterial blood pressures and heart rates re-
mained constant and did not show marked differences be-
tween groups. GFP-uv E. coli w e r e  d e t e c t e d  a s  s i n g l e
fluorescent rods or small clusters of bacteria in the submu-
cosal stroma and, subsequently, in the muscularis propria
of the small bowel wall using serosa sided intravital mi-
croscopy.
Transit time of bacterial translocation
During non-ischemic obstruction bacterial translocation
into the submucosa and muscularis propria took a mean
of 36 ± 8 min and 80 ± 10 min, respectively (Figure 2).
Ischemia of the obstructed small bowel resulted in a sig-
nificant acceleration of minimal transit time into the sub-
mucosa (11 ± 5 min, p < 0.0001) and muscularis propria
(66 ± 7 min; p = 0.004).
Small bowel microflora and bacterial examination of tis-
sue
The variety of gram-positive and gram-negative bacteria
per ml of stool from the small bowel proximal of the ob-
structed bowel segment and from the obstructed loop of
terminal ileum did not show any quantitative nor qualita-
tive differences in any groups. The most common bacteria
found in the terminal ileum were fermentative and non-
fermentative gram-negative rods, Streptococci and Sta-
phylococcus aureus. GFP-uv E. coli predominated among
these species in the stool from the obstructed loop (Table
1). The same species were found in homogenized me-
senteric lymph nodes, liver and spleen. There were no dif-
ferences between ischemic and non-ischemic animals
regarding gram-positive and gram-negative intestinal mi-
croflora. Bacterial translocation to mesenteric lymph
nodes, liver and spleen was not present in sham operated
animals. Bacterial smears from the abdominal cavity were
negative in all animals.
Histopathology
Ischemic lesions
No or minor mucosal lesions (grade 0–1) were found in
HE stained specimens of obstructed terminal ileum in
non-ischemic animals. Severe lesions (grade 3) were
present in all animals subjected to ischemic small bowel
obstruction. Specimens from unaffected terminal ileum
proximal to the obstructed loop and from sham operated
animals demonstrated no mucosal lesions in both groups
of animals (grade 0).
Bacterial translocation to distant organs
Bacterial translocation to distant organs was confirmed by
fluorescence microscopy on crossections of frozen tissue
taken from the obstructed small bowel segment, liver and
spleen two hours after injection of GFP-uv E. coli. GFP-uv
E. coli were found adherent to the mucosa, penetrating the
mucosa and translocating into the submucosal stroma
(Figure 3), the muscularis propria and the attached me-
sentery in tissue of the obstructed small bowel loop. Sin-
gle GFP-uv E. coli or small clusters of bacteria were also
found in specimens taken from liver and spleen. Translo-
cation of GFP-uv E. coli was observed in all animals sub-
jected to injection of GFP-uv E. coli on intravital
microscopy. On frozen sections too, GFP-uv E. coli were
detected in all of these animals without any differences
between non-ischemic and ischemic obstruction. No flu-
orescent bacteria were found in sham operated animals
(Table 2).
Discussion
Translocation of intestinal bacteria has been observed as a
spontaneous event in humans [24] leading some authors
to question its clinical significance [25]. Others, however,
consider bacterial translocation to be a crucial factor in
the pathogenesis of sepsis and multiple organ failure in
surgical and intensive care patients [15,25,26]. Intestinal
obstruction [17] and ischemia are among the conditions
most likely to be associated with bacterial translocation
and sepsis. A failure of the intestinal barrier function, re-
Figure 2
Time intervals of bacterial translocation to the submucosal
stroma and the muscularis propria during ischemic and non-
ischemic small bowel obstruction in minutes after intralumi-
nal administration of GFP-uv E. coli. The vertical bars repre-
sent means ± s.d. and demonstrate significant differences in
bacterial transit into the submucosa (*p < 0.0001) and the
muscularis propria (°p = 0.004) between animals subjected to
non-ischemic vs. ischemic bowel obstruction (Student's t-
test, p < 0.05).BMC Surgery 2002, 2 http://www.biomedcentral.com/1471-2482/2/6
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sulting in an increase of mucosal permeability, has been
hypothesized to be a major promoter of bacterial translo-
cation [8].
In order to understand its pathophysiological relevance,
bacterial translocation has been studied in animals sub-
jected to various pathological conditions such as hemor-
rhagic shock [27], endotoxin-challenge [28], thermal
body surface trauma [29], acute pancreatitis [30] and in-
testinal obstruction [31] and ischemia [19]. Animal mod-
els, developed to study mucosal permeability, involved
the use of specific markers to follow the bacterial passage
across the mucosa. Inulin-fluorescein was used to study
permeability of the mucosa in inflamed small and large
bowel. Permeability was determined by analyzing plas-
ma-levels of the marker [10]. Others measured plasma
levels of polyethylene glycol 4000 [11] or used fluores-
cence-activated cell sorting of fluorescent microspheres
[12] that had been administered into the small bowel, to
show an altered mucosal permeability during hemorrhag-
ic shock and acute pancreatitis respectively. The most de-
tailed proof of a gut-origin of endogenous infections was
provided by the detection of plasmid-labelled E. coli in
pancreatic tissue of pancreatitic dogs via plasmid DNA
analysis, seven days after colonizing them with a strain of
E. coli bearing the plasmid pUC4K [13].
In contrast to these more indirect approaches to demon-
strate and investigate bacterial translocation, we devel-
oped a rat model allowing us to observe the passage of
viable fluorescent E. coli, that had been injected into an
obstructed small bowel segment, across the mucosa and
into the muscularis propria, and their further transloca-
tion to extraintestinal organs such as the liver and spleen.
Table 1: Indigenous small bowel microflora in rats Bacterial species found in the terminal ileum of sham operated animals and ischemic 
and non-ischemic rats after intraluminal injection of GFP-uv E. coli (E. coli = Escherichia coli; Past. = Pasteurella; Strept. = Streptococcus; 
S. = Staphylococcus; Bac. = Bacillus).
stool from the terminal ileum stool from obstructed terminal ileum
Species Sham operated non-ischemic 
obstruction
ischemic obstruction non-ischemic 
obstruction
ischemic obstruction
GFP-E. coli ---+ +
E. coli +++++
S. aureus +++++
Strept. spp. +++++
Past. spp. +++++
Bac. spp. +++++
Table 2: Incidence of GFP-uv E. coli translocation to distant organs
Group Organ number of GFP-uv E. coli per HPF (mean + 
s.d.)
sham operated MLN none
liver none
spleen none
non-ischemic obstruction MLN 1.8 ± 0.7
liver 2.9 ± 1.2
spleen 2.0 ± 0.9
ischemic obstruction MLN 2.0 ± 0.9
liver 2.8 ± 1.0
spleen 1.8 ± 0.7
MLN = mesenteric lymph nodes; HPF = high power fieldBMC Surgery 2002, 2 http://www.biomedcentral.com/1471-2482/2/6
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Online intravital microscopy allowed the assessment of
the minimal time period necessary for GFP-uv E. coli to
translocate into the submucosal stroma and muscularis
propria (≥  5 E. coli per HPF in 10 HPFs). We defined min-
imal transit time as a novel parameter characterizing intes-
tinal barrier function in this model of small bowel
obstruction.
Intestinal obstruction in our model was associated with
translocation of GFP-uv E. coli within less than an hour af-
ter intraluminal administration of the bacteria. When we
examined specimens of small bowel on crossections, we
did not find severe mucosal damage in animals subjected
to intestinal obstruction. Deitch and co-workers also
found no mucosal damage during bowel obstruction and
suggested that changes in the intestinal microflora and in-
fectious mechanisms may promote bacterial translocation
[16]. In our study, however, bacteriological examination
did not reveal any differences in the variety of intestinal
micro-organisms in the non-obstructed or obstructed ter-
minal ileum. We assume that even the moderate disten-
sion of the bowel by intraluminal administration of the E.
coli suspension promoted bacterial translocation. A possi-
ble explanation for bacterial translocation resulting from
bowel distension may be a loss of mucosal tight junction
integrity.
The specific effect of segmental ischemia of the obstructed
small bowel, in our study, was a marked acceleration of
bacterial translocation. Ischemic mucosal injury, as de-
tected by histopathological examination probably corre-
lates with a breakdown of the intestinal barrier function.
The concept that intestinal hypoperfusion and ischemia
promote bacterial translocation is well established in lit-
erature [16,31–33]. By using our novel animal model, we
can provide further functional and histopathological evi-
dence supporting the hypothesis of a gut origin of micro-
organisms that translocate to extraintestinal organs under
pathological conditions. This animal model was used to
study bacterial translocation in ischemic and non-ischem-
ic small bowel obstruction. Bacterial translocation ob-
served in this model was initiated by inflammatory stress
due to obstruction and distension of the gut. Gut ischemia
serves as an additional promoter of bacterial translocation
in this model. We were able to study the minimal transit
time necessary for bacterial translocation across the intes-
tinal barrier by means of intravital microscopy. Thus we
have introduced an additional experimental tool to inves-
tigate specific pathological effects on intestinal barrier
function. However, the quantification of bacterial translo-
cation across the intestinal barrier into distant organs is
difficult to accomplish in this model and may require a
longer period of observation. GFP-uv E. coli are adminis-
tered into the stool contained in the obstructed small
bowel, which probably results in an uneven distribution
along the mucosa. The number of translocated GFP-uv E.
coli found in mesenteric lymph nodes, liver and spleen
varied, but did not show significant differences between
animals subjected to ischemic and non-ischemic bowel
obstruction. Transit time did not correlate to the number
of GFP-uv E. coli / HPF found in mesenteric lymph nodes,
liver and spleen two hours after GFP-uv E. coli administra-
tion. Further elaboration of the model is needed to pro-
vide quantitative measures of bacterial translocation.
Conclusions
The presented animal model allows an online assessment
of bacterial translocation by means of intravital microsco-
py. In addition to previous animal models of bacterial
translocation, our novel approach defines minimal bacte-
rial transit time as a function of the intestinal barrier and
demonstrates a significant influence of ischemic injury of
the gut on bacterial translocation. This novel parameter of
intestinal barrier function can contribute to the under-
standing of bacterial translocation. The model allows
studies of bacterial translocation under various patholog-
ical conditions, e.g. acute pancreatitis or increased in-
traabdominal pressure. Furthermore the impact of
pharmacological agents on intestinal barrier function can
be examined in this model. However, further studies are
needed to determine the clinical significance of this novel
kinetic parameter.
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